Peter T. Nower

Statistics

Publications

Citations

1.2K

H-Index

Active since

1997

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Peter T. Nower is an author at Bristol-Myers Squibb (United States) specializing in antiviral pharmacology, molecular virology, and antiviral therapy.

Publications per year

1997–2015

Publications

Genotypic and phenotypic analysis of variants resistant to hepatitis C virus nonstructural protein 5A replication complex inhibitor BMS-790052 in Humans: In Vitro and In Vivo Correlations

Robert A. Fridell, Chunfu Wang, Jin-Hua Sun et al. · Hepatology · 2010 · 228 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Identification of Hepatitis C Virus NS5A Inhibitors

Julie A. Lemm, Donald R. O’Boyle, Mengping Liu et al. · Journal of Virology · 2009 · 194 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

Persistence of Resistant Variants in Hepatitis C Virus-Infected Patients Treated with the NS5A Replication Complex Inhibitor Daclatasvir

Chunfu Wang, Jin-Hua Sun, Donald R. O’Boyle et al. · Antimicrobial Agents and Chemotherapy · 2013 · 94 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Inhibitors of HCV NS5A: From Iminothiazolidinones to Symmetrical Stilbenes

J. Romine, Denis R. St. Laurent, John E. Leet et al. · ACS Medicinal Chemistry Letters · 2011 · 86 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Development of a Cell-Based High-Throughput Specificity Screen Using a Hepatitis C Virus-Bovine Viral Diarrhea Virus Dual Replicon Assay

Donald R. O’Boyle, Peter T. Nower, Julie A. Lemm et al. · Antimicrobial Agents and Chemotherapy · 2005 · 67 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +13

1–5 of 19